MedTrace Logo

Thromboelastography During Surgery for Malignant Pleural Mesothelioma

NCT01912547 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2015-01-30

No results posted yet for this study

Summary

Surgery for malignant pleural mesothelioma is complex and prolonged, and may involve significant blood loss with considerable blood and product transfusion. Thromboelastography (TEG) is a global assay of coagulation that uses whole blood to produce a tracing that records kinetic changes in clot formation. This study aims provide a better understanding of the coagulation profile of these patients, and will form the basis of a TEG-based transfusion algorithm for future surgeries for mesothelioma.

Conditions

Interventions

PROCEDURE

Blood draw for TEG analysis

Blood drawn for TEG analysis

Sponsors & Collaborators

  • Brigham and Women's Hospital

    lead OTHER

Principal Investigators

  • Ju-Mei Ng, MD · BWH

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-09-30
Primary Completion
2015-12-31
Completion
2015-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01912547 on ClinicalTrials.gov